PreprintCC BYmedRxiv
Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo
- 1Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles
Abstract
We report general acceptance (79.0%) of Ebola vaccination in the Democratic Republic of the Congo (DRC) between 2023-2024 (n=5,062). Acceptance varied significantly by province with acceptance ranging from 47.6% in Kongo Central to 92.1% in Tshuapa province and was highest among healthcare workers. While Ebola vaccine acceptance and disease knowledge are relatively strong nationally in the DRC, regional differences do exist and may impact future vaccine rollout.
Related
- Notes from the Field: Outbreak of Ebola Disease Caused by Bundibugyo Virus — Democratic Republic of the Congo and Uganda, May 2026
- Knowledge, attitudes, and practices regarding priority zoonotic diseases (Mpox, Ebola, and Rabies) and associated factors among households in Bukavu, Democratic Republic of the Congo, 2025
- Temporal and Phylodynamic analyses of the 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo
- Case of Bundibugyo Virus Disease in Goma, Democratic Republic of the Congo with Lack of Transmission to Breastfeeding Infant.
- Sexual and Reproductive Health Knowledge, Attitudes, Practices and Associated Factors Among School-Going Adolescents in Conflict-Affected Eastern Democratic Republic of Congo: A Cross-Sectional Study.
BibTeX
@misc{merritt2026ebola,
title = {{Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo}},
author = {S. Merritt and J. Kindrachuk and D. Nkamba and N. A. Hoff and H. Kalengi and M. Halbrook and L. Kamba and M. Beya and S. Petrichko and H. L. Wallace and C. Luhata and D. Kaba and A. W. Rimoin},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.26365673},
url = {https://www.medrxiv.org/content/10.64898/2026.10.15.26365673v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo
AU - S. Merritt
AU - J. Kindrachuk
AU - D. Nkamba
AU - N. A. Hoff
AU - H. Kalengi
AU - M. Halbrook
AU - L. Kamba
AU - M. Beya
AU - S. Petrichko
AU - H. L. Wallace
AU - C. Luhata
AU - D. Kaba
AU - A. W. Rimoin
PY - 2026
DA - 2026/10/15
PB - medRxiv
DO - 10.64898/2026.10.15.26365673
UR - https://www.medrxiv.org/content/10.64898/2026.10.15.26365673v1
AB - We report general acceptance (79.0%) of Ebola vaccination in the Democratic Republic of the Congo (DRC) between 2023-2024 (n=5,062). Acceptance varied significantly by province with acceptance ranging from 47.6% in Kongo Central to 92.1% in Tshuapa province and was highest among healthcare workers. While Ebola vaccine acceptance and disease knowledge are relatively strong nationally in the DRC, regional differences do exist and may impact future vaccine rollout.
ER -